COLL · Collegium Pharmaceutical, Inc
$35.54
-0.54 (-1.50%)
At close · Jul 20
Market Cap
$1.15B
Shares
32.43M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K/A | 2026-06-30 | 2026-05-12 | |
| 8-K | 2026-05-15 | 2026-05-14 | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| 8-K | 2026-04-07 | 2026-04-02 | |
| DEF 14A | 2026-04-07 | 2026-05-14 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-03-19 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-01-08 | — | |
| 8-K | 2025-12-30 | 2025-12-23 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-07-07 | 2025-07-01 | |
| 8-K | 2025-05-19 | 2025-05-15 | |
| 8-K | 2025-05-12 | — | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-03-28 | 2025-05-15 | |
| 8-K | 2025-03-17 | 2025-03-11 | |
| 8-K | 2025-02-27 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-05 | 2025-02-03 | |
| 8-K | 2025-01-08 | — | |
| 8-K/A | 2024-11-14 | 2024-09-03 | |
| 8-K | 2024-11-07 | 2024-11-06 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-09-04 | 2024-09-03 | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-07-29 | 2024-07-28 | |
| 8-K | 2024-06-13 | — | |
| 8-K | 2024-05-24 | — | |
| 8-K | 2024-05-20 | 2024-05-16 | |
| 8-K | 2024-05-13 | — | |
| 8-K | 2024-05-10 | 2024-05-09 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-04-29 | 2024-04-26 | |
| 8-K | 2024-04-11 | — | |
| DEF 14A | 2024-04-05 | 2024-05-16 | |
| 10-K | 2024-02-22 | 2023-12-31 | |
| 8-K | 2024-02-22 | — | |
| 8-K | 2024-01-03 | 2024-01-01 |
Showing 1–50 of 117 filings
Key facts
CIK
1267565
CUSIP
19459J104
13F (30d)
22 filings
22 filers
Visit website
Investor relations